Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia
- 1Neuroscience Program, Michigan State University
- 2Department of Physiology, Michigan State University
Abstract
Chronic pain affects more than one-fifth of adults in the United States and represents a major public health burden due to its impact on quality of life, productivity, and healthcare costs. Current pharmacological treatments remain limited in efficacy and are often associated with significant adverse effects, highlighting the need for safer and more effective therapeutic strategies. Neurotensin (Nts), a neuropeptide widely expressed in the central and peripheral nervous systems, has emerged as an important modulator of nociceptive processing. Nts signals through the G protein-coupled receptors neurotensin receptor 1 (NTSR1) and neurotensin receptor 2 (NTSR2), which are expressed in key neuroanatomical components of pain pathways. In this review, we summarize current knowledge of the neuronal and molecular mechanisms underlying pain processing and discuss how Nts signaling modulates nociceptive transmission at peripheral, spinal, and supraspinal levels. In addition to regulating nociceptor excitability and spinal excitatory neurotransmission, Nts critically regulates neural circuits involved in descending pain modulation, including the periaqueductal gray and rostral ventromedial medulla, and contributes to pain processing within limbic and hypothalamic networks that integrate sensory and affective components of pain. Finally, we discuss recent advances in pharmacological modulation of Nts receptors, including biased allosteric modulators and receptor-selective agonists that show promising analgesic efficacy in preclinical models. Together, these findings position the neurotensin system as a promising target for the development of novel non-opioid therapies for pain.
Related
- Enteroendocrine signaling in irritable bowel syndrome: beyond cell counts toward stimulus-responsive physiological profiling
- Targeting cyclic-AMP/phosphodiesterase signaling to quiet nasal tuft cell calcium responses
- Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
- Single-cell RNA Sequencing Analysis Reveals That Targeting PLG–PLGRKT Signaling-mediated Pro-fibrotic Scar-associated Macrophages Ameliorates Liver Fibrosis in Biliary Atresia
- Targeting P2Y₁₄R inhibits proliferation of cervical cancer cells and organoids and activates cAMP/PKA/CREB signaling pathway.
BibTeX
@article{chapman2026targeting,
title = {{Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia}},
author = {Alex D. Chapman and Katherine L. Black and Gina M. Leinninger and Geoffroy Laumet},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1907900},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1907900/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia
AU - Alex D. Chapman
AU - Katherine L. Black
AU - Gina M. Leinninger
AU - Geoffroy Laumet
PY - 2026
DA - 2026/10/14
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1907900
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1907900/full
AB - Chronic pain affects more than one-fifth of adults in the United States and represents a major public health burden due to its impact on quality of life, productivity, and healthcare costs. Current pharmacological treatments remain limited in efficacy and are often associated with significant adverse effects, highlighting the need for safer and more effective therapeutic strategies. Neurotensin (Nts), a neuropeptide widely expressed in the central and peripheral nervous systems, has emerged as an important modulator of nociceptive processing. Nts signals through the G protein-coupled receptors neurotensin receptor 1 (NTSR1) and neurotensin receptor 2 (NTSR2), which are expressed in key neuroanatomical components of pain pathways. In this review, we summarize current knowledge of the neuronal and molecular mechanisms underlying pain processing and discuss how Nts signaling modulates nociceptive transmission at peripheral, spinal, and supraspinal levels. In addition to regulating nociceptor excitability and spinal excitatory neurotransmission, Nts critically regulates neural circuits involved in descending pain modulation, including the periaqueductal gray and rostral ventromedial medulla, and contributes to pain processing within limbic and hypothalamic networks that integrate sensory and affective components of pain. Finally, we discuss recent advances in pharmacological modulation of Nts receptors, including biased allosteric modulators and receptor-selective agonists that show promising analgesic efficacy in preclinical models. Together, these findings position the neurotensin system as a promising target for the development of novel non-opioid therapies for pain.
SN - 1663-9812
ER -